Histology and Cytology Market Size, Share, Growth, Trends with Impact of Covid-19 and Forecast by 2022-2030

Detailed TOC of Histology and Cytology Market Size, Share, Growth, Trends with Impact of Covid-19 and Forecast by 2022-2030

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Cancer
4.2.2 Increasing Standardization of Pathological Laboratories
4.2.3 Technological Advancements in Diagnostic and Molecular Techniques
4.2.4 Favorable Reimbursements for Cancer Screening and Laboratory Tests
4.3 Market Restraints
4.3.1 Safety Issues and Diagnostic Accuracy Issues with Histopathological and Cytopathological Tests
4.3.2 Lack of Awareness among the Public for Diagnostic Tests
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type of Examination
5.1.1 Histology
5.1.2 Cytology
5.1.2.1 Breast Cancer
5.1.2.2 Cervical Cancer
5.1.2.3 Others
5.2 By Test Type
5.2.1 Microscopy Tests
5.2.1.1 Cytogenic Tests
5.2.1.1.1 Karyotyping
5.2.1.1.2 Fluorescent In-situ Hybridization (FISH)
5.2.1.2 Polymerase Chain Reaction
5.2.1.3 Others
5.2.2 Molecular Genetics Tests
5.2.3 Flow Cytomtery
5.3 By End User
5.3.1 Hospitals/Clinics
5.3.2 Biopharmaceutical Companies
5.3.3 Academia
5.3.4 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott
6.1.2 Becton Dickinson and Company
6.1.3 Danaher
6.1.4 F. Hoffmann-La Roche Ltd
6.1.5 Hologic Inc.
6.1.6 Merck & Co. Inc.
6.1.7 PerkinElmer Inc.
6.1.8 Sysmex Corporation
6.1.9 Thermo Fisher Scientific Inc.
6.1.10 Trivitron Healthcare

7 MARKET OPPORTUNITIES AND FUTURE TRENDS